Prognosis of COPD depends on severity of exacerbation history: A population-based analysis

被引:31
作者
Colak, Yunus [1 ,2 ,3 ,4 ]
Afzal, Shoaib [1 ,2 ,3 ,4 ]
Marott, Jacob L. [2 ,3 ]
Nordestgaard, Borge G. [1 ,2 ,3 ,4 ]
Vestbo, Jorgen [5 ,6 ]
Ingebrigtsen, Truls S. [2 ,3 ,7 ]
Lange, Peter [2 ,3 ,4 ,8 ,9 ]
机构
[1] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark
[2] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Herlev, Denmark
[3] Copenhagen Univ Hosp, Bispebjerg & Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[5] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biol Sci, Div Infect Immun & Resp Med, Manchester, Lancs, England
[6] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England
[7] Copenhagen Univ Hosp, Hvidovre Hosp, Resp Sect, Med Unit, Hvidovre, Denmark
[8] Univ Copenhagen, Sect Epidemiol, Dept Publ Hlth, Copenhagen, Denmark
[9] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Sect Resp Med, Dept Internal Med, Herlev, Denmark
关键词
Airway obstruction; Spirometry; Forced expiratory volume; Chronic bronchitis; Emphysema; OBSTRUCTIVE PULMONARY-DISEASE; 2017; CLASSIFICATION; NATURAL-HISTORY; MORTALITY; PREDICTION; FREQUENCY; HOSPITALIZATION; DECLINE; SMOKERS; TIME;
D O I
10.1016/j.rmed.2019.07.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Differences in previous exacerbation history may influence prognosis of chronic obstructive pulmonary disease (COPD). We hypothesized that prognosis differs between individuals with a history of only medically treated exacerbations (moderate exacerbations) and those with a history of hospitalised exacerbations (severe exacerbations). Methods: We included 98 614 adults from the Copenhagen General Population Study and assessed risk of moderate and severe exacerbations, pneumonia hospitalisation, and respiratory and all-cause mortality from 2003 until 2013 according to exacerbation history. Results: Among 6545 individuals with COPD, 6290 had no exacerbations in the preceding year, 109 had one moderate exacerbation, 108 had two or more moderate exacerbations, and 38 had one or more severe exacerbations. During 9.4 years of follow-up, we observed 926 moderate and 244 severe exacerbations, 477 pneumonias, and 707 deaths, including 69 from respiratory disease. Compared to individuals without previous exacerbations, lung function and symptom adjusted hazard ratios (HRs) for future moderate exacerbation were 4.68 (95% confidence interval: 3.31-6.62) for individuals with one previous moderate exacerbation, 21 (13-33) for individuals with two or more previous moderate exacerbations, and 5.30 (3.44-8.15) for individuals with one or more previous severe exacerbations. Corresponding HRs were 1.62(0.78-3.34), 1.29(0.57-2.89), and 5.43 (2.56-12) for severe exacerbation, 1.86(1.06-3.27), 1.74(1.01-2.99), and 4.85 (2.94-8.02) for pneumonia, 0.53(0.10-2.99), 1.65(0.53-5.17), and 2.98 (1.14-7.83) for respiratory mortality, and 1.34(0.79-2.29), 1.57(1.00-2.47), and 1.49 (0.85-2.62) for all-cause mortality, respectively. Conclusion: Individuals with COPD and a history of hospitalised exacerbations carried the poorest prognosis compared to those with a history of only medically treated exacerbations, suggesting difference in risk profile.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 31 条
  • [1] Regression analysis of restricted mean survival time based on pseudo-observations
    Andersen, PK
    Hansen, MG
    Klein, JP
    [J]. LIFETIME DATA ANALYSIS, 2004, 10 (04) : 335 - 350
  • [2] [Anonymous], 2016, Fact Sheet
  • [3] Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study
    Colak, Yunus
    Afzal, Shoaib
    Nordestgaard, Borge G.
    Vestbo, Jorgen
    Lange, Peter
    [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (05) : 426 - 434
  • [4] Factors associated with change in exacerbation frequency in COPD
    Donaldson, Gavin C.
    Muellerova, Hanna
    Locantore, Nicholas
    Hurst, John R.
    Calverley, Peter M. A.
    Vestbo, Jorgen
    Anzueto, Antonio
    Wedzicha, Jadwiga A.
    [J]. RESPIRATORY RESEARCH, 2013, 14
  • [5] Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
    Donaldson, GC
    Seemungal, TAR
    Bhowmik, A
    Wedzicha, JA
    [J]. THORAX, 2002, 57 (10) : 847 - 852
  • [6] Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease
    Dransfield, Mark T.
    Kunisaki, Ken M.
    Strand, Matthew J.
    Anzueto, Antonio
    Bhatt, Surya P.
    Bowler, Russell P.
    Criner, Gerard J.
    Curtis, Jeffrey L.
    Hanania, Nicola A.
    Nath, Hrudaya
    Putcha, Nirupama
    Roark, Sarah E.
    Wan, Emily S.
    Washko, George R.
    Wells, J. Michael
    Wendt, Christine H.
    Make, Barry J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (03) : 324 - 330
  • [7] A proportional hazards model for the subdistribution of a competing risk
    Fine, JP
    Gray, RJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) : 496 - 509
  • [8] Lung function impairment, COPD hospitalisations and subsequent mortality
    Garcia-Aymerich, Judith
    Pons, Ignasi Serra
    Mannino, David M.
    Maas, Andrea K.
    Miller, David P.
    Davis, Kourtney J.
    [J]. THORAX, 2011, 66 (07) : 585 - 590
  • [9] Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
    Gedebjerg, Anne Y.
    Szepligeti, Szimonetta Komjathine
    Wackerhausen, Laura-Maria Holm
    Horvath-Puho, Erzsebet
    Dahl, Ronald
    Hansen, Jens Georg
    Sorensen, Henrik Toft
    Norgaard, Mette
    Lange, Peter
    Thomsen, Reimar Wernich
    [J]. LANCET RESPIRATORY MEDICINE, 2018, 6 (03) : 204 - 212
  • [10] Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD
    Groenewegen, KH
    Schols, AMWJ
    Wouters, EFM
    [J]. CHEST, 2003, 124 (02) : 459 - 467